Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma
暂无分享,去创建一个
K. De Preter | M. Haber | M. Norris | B. Cheung | Shoma Tsubota | A. Beckers | Daniel R. Carter | Anushree Balachandran | Janith A. Seneviratne | Frank Speleman | Alexander Swarbrick | Glenn M Marshall | Lei Zhai | Rebecca Larkin | Sylvia A. Chung | Amit Lalwani | Dominik Beck | Kenji Kadomatsu | Kaat Durink